Intense Pulsed Light in Meibomian Gland Dysfunction

Last updated: October 20, 2021
Sponsor: Prim. Prof. Dr. Oliver Findl, MBA
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dry Eyes

Dry Eye Disease

Eyelid Inflammation

Treatment

N/A

Clinical Study ID

NCT05089591
IPL
  • Ages > 18
  • All Genders

Study Summary

Meibomian gland dysfunction (MGD) is a major cause of dry eye disease (DED). Up to 86% of patients suffering from DED also show signs of MGD. Traditional treatment of MGD is based on eye lid hygiene and massage in combination with intensive usage of lubricants.

Recently, a novel technology the intense pulsed light (IPL) therapy was introduced, which shows promising results in patients with meibomian gland dysfunction. Originating from field of dermatology, subjecting improvement of dry eye symptoms was recognized after the treatment of facial rosacea using IPL. Different hypotheses exist how IPL treatment might improve the situation in the dry eye patient. Warming of the eyelid, due to the light application and reduction of bacterial load are two possible mode of actions. Further, the used wavelengths in IPL may be modified that the light is only absorbed by oxygenated haemoglobin, which lead to an obliteration of telangiectasia and reduced inflammation on the lid margin. This principal is applied in the treatment of facial rosacea.

Aim of this study is to investigate the effect of IPL therapy in patients with MGD on dry eye parameters as well as subjective complaints.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age older than 18 years
  • Presence of meibomian gland dysfunction at any stage
  • Presence of meibomian glands on each lower eyelid's Meibography

Exclusion

Exclusion Criteria:

  • Fitzpatrick Skin Type VI
  • Usage of eye drops other than lubricants (e.g. antibiotics, steroids, cyclosporin-A)
  • Usage of systemic antibiotic therapy
  • Any pathology of the ocular surface except dry eye disease (e.g. corneal scarring,cornea ectasia)
  • Ocular surgery within prior 3 months
  • Ocular injury within prior 3 months
  • Ocular herpes of eye or eyelid within prior 3 months
  • Active ocular infection
  • Active ocular inflammation or history of chronic, recurrent ocular inflammation withinprior 3 months
  • Eyelid abnormalities that affect lid function
  • Ocular surface abnormality that may compromise corneal integrity
  • Pregnancy

Study Design

Total Participants: 38
Study Start date:
October 20, 2021
Estimated Completion Date:
November 01, 2022

Connect with a study center

  • Vienna Institute for Research in Ocular Surgery

    Vienna, 1140
    Austria

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.